Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impotence after prostatectomy.

T F Lue1

  • 1University of California School of Medicine, San Francisco.

The Urologic Clinics of North America
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Post-prostatectomy impotence affects 4-30% of patients, with surgical technique a potential cause. This review covers incidence, mechanisms, and management of neurovascular impotence after prostatectomy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective, randomized, placebo-controlled trial of on-Demand vs. nightly sildenafil citrate as assessed by Rigiscan and the international index of erectile function.

Andrology·2015
Same author

Direct androgen regulation of PDE5 gene or the lack thereof.

International journal of impotence research·2013
Same author

How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie's disease.

International journal of impotence research·2013
Same author

A coculture system of cavernous endothelial and smooth muscle cells.

International journal of impotence research·2012
Same author

Tracking intracavernously injected adipose-derived stem cells to bone marrow.

International journal of impotence research·2011
Same author

Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical management.

International journal of impotence research·2011
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Area of Science:

  • Urology
  • Andrology
  • Surgical Oncology

Background:

  • Prostatectomy is a common treatment for prostate cancer.
  • Post-surgical erectile dysfunction (ED) is a significant concern for patients undergoing prostatectomy.
  • Reported incidence of impotence ranges from 4% to 30%.

Purpose of the Study:

  • To examine the incidence and mechanisms of neurovascular impotence following prostatectomy.
  • To outline current evaluation and treatment strategies for post-prostatectomy impotence.

Main Methods:

  • Review of existing literature on prostatectomy outcomes and erectile dysfunction.
  • Analysis of surgical techniques and their impact on neurovascular structures.
  • Synthesis of data on the incidence, pathophysiology, and management of post-prostatectomy impotence.

Related Experiment Videos

Main Results:

  • A significant percentage of patients experience impotence after prostatectomy.
  • Surgical technique is a contributing factor to neurovascular impotence.
  • Various evaluation methods and treatment options are available.

Conclusions:

  • Understanding the mechanisms of impotence is crucial for surgical planning.
  • Early and accurate diagnosis can improve treatment outcomes.
  • Management strategies should be tailored to individual patient needs.